Fortress Biotech Inc
F:CNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
A
|
Abbott Laboratories
XETRA:ABL
|
US |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
Doubleview Gold Corp
F:1D4
|
CA |
|
DFDS AS
F:29K
|
DK |
|
C
|
CDW Corp
DUS:CDW
|
US |
Wall St Price Targets
CNB Price Targets Summary
Fortress Biotech Inc
According to Wall Street analysts, the average 1-year price target for CNB is 15.632 EUR with a low forecast of 7.036 EUR and a high forecast of 24.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNB's stock price target?
Price Target
15.632
EUR
According to Wall Street analysts, the average 1-year price target for CNB is 15.632 EUR with a low forecast of 7.036 EUR and a high forecast of 24.87 EUR.
What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
47%
The compound annual growth rate for Revenue over the next 2 years is 47%.
What is the Gross Profit forecast for Fortress Biotech Inc?
Projected CAGR
63%
The compound annual growth rate for Gross Profit over the next 2 years is 63%.
